Now, it has decided to publish a special report on two of GSK's COPD therapies – Breo Ellipta (fluticasone furoate and vilanterol) and Trelegy Ellipta (fluticasone furoate, umeclidinium ...

Relvar Ellipta is a once-daily dual combination treatment comprising fluticasone furoate, an inhaled corticosteroid and vilanterol, a long-acting beta2-agonist, in a single inhaler, the Ellipta.

Objective: Single inhaler triple therapy is widely used in Chronic Obstructive Pulmonary Disease (COPD) and asthma. This research aimed to analyze adverse events (AEs ...

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...

If your symptoms don't improve with those methods, these over-the-counter medications may help ease symptoms. Decongestants ...

If your symptoms don't improve with those methods, these over-the-counter medications may help ease symptoms. Decongestants (oral or nasal) Nasal steroid sprays, such as Nasonex (mometasone furoate ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Drugs to treat cancer and type 2 diabetes are among ...

Medicare is set to negotiate with manufacturers on 15 drugs in an effort to lower their prices for consumers nationwide. The Biden Administration announced that the Inflation Reduction Act cut the ...